1) COVID-19 Has Driven Revenue Up 77%
The headline revenue data (summarised below) provides very positive news for AmWell and its new investor, Google. Notably:
- Even prior to COVID-19, the company was growing well with revenues increasing by 31% in 2019 compared to 2018.
- This rate of growth has accelerated in 1H20, with overall revenue up 77% in the same period in 2019.
- The 2019 growth was partly driven by a small increase in the number of health plan subscription customers and
Read More
Alex Green, Director at Signify Research
Alex Green is the Director and Principal Analyst at Signify Research, a UK-based market research firm focusing on health IT, digital health, and medical imaging. Alex is responsible for leading Signify Research’s Digital Health market intelligence portfolio, initially developing its coverage of the patient engagement platforms and portals market
COVID-19 and Its Global Impact on Primary Care Virtual Consultations
Last week saw Teladoc Health release its 1Q20 financial results giving the US telehealth industry a first glimpse of how COVID-19 is impacting the ambulatory virtual care market. Discussion around the crisis and its impact on telehealth has been rife since early March and the data published by Teladoc Health highlights that this was justified.
The company reported that the number of virtual care consults in the quarter had passed the 2 million mark, up approximately 60% from the 1.24M
Read More
Dedalus to Acquire Agfa’s HCIS Business: Impact on European EMR Market
Yesterday Agfa announced it had entered exclusive negotiations with Dedalus Holding to sell part of its Healthcare IT business, specifically the business tied to its EMR and Integrated Care offerings. The facts are:- In May 2019 Agfa stated it would explore selling its Hospital IT and Integrated Care (HCIS) solutions business.- This process was brought a step forward towards the conclusion yesterday with the announcement that the deal (valued at €945M) would be completed during Q2 2020, and
Read More
Health Catalyst IPO Journey: Future Opportunities & Challenges to Watch
Libby Greene, NASDAQ
Last week saw Health Catalyst common stock begin trading on the Nasdaq Global Select Market. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximized the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive
Read More
Analysis: Cerner, Epic, Allscripts and MEDITECH’s International EHR Endeavours
In this insight, we assess how the top US acute EHR vendors, namely Epic, Cerner, Allscripts and MEDITECH (+85% share of US acute market in terms of revenues), have progressed specifically on the third point, international expansion.The below figure shows that there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $600M in 2018, representing 12% of its business. Whilst MEDITECH has much
Read More
Analysis: Examining The Highly Fragmented International EHR Market
The EMEA market for EMR/EHR IT is estimated to have been worth $3.7B in 2018 (both acute and ambulatory applications) according to Signify Research’s recently published market report on the global EMR/EHR market. However, only one vendor, Cerner, is estimated to have had a double-digit revenue share. Despite its recent announcement that it will potentially sell its Hospital IT and Integrated Care business, Agfa Health was the only other vendor to come close. In terms of suppliers, the market is
Read More
Healthcare M&A: Agfa to Consider Selling Health IT & Integrated Care Business
Last week Agfa announced its Board of Directors would investigate the sale of part of Agfa HealthCare, specifically, the business tied to its EMR and integrated care offerings. The facts are:· In March 2019, Agfa initially stated that it would further extend the independence of Agfa HealthCare.· It has now expanded on what this could potentially look like, stating it will explore selling is Hospital IT and Integrated Care solutions.· In terms of its reportable business this is largely the
Read More
HIMSS19 Agrees – 2019 Will be a Big Year for Telehealth
Telehealth has been a key theme at HIMSS for several years now; that said, it has never quite lived up to its own hype and to some extent has been viewed as a “niche” area compared to some of its bigger brothers such as EHR and population health. The back-end of 2018 and start of 2019 saw developments that are likely to change this in the near future.The Centers for Medicare & Medicaid Services (CMS) updated several of its guidance models and the 2019 physician fee schedule in relation to
Read More
4 Trends We Expect to See at HIMSS 2019
In less than two weeks, 45,000 health IT professionals, clinicians, executives and “technology superheroes” (a HIMSS’ term, not ours – but one we’re going to run with) will descend on Orlando for the annual HIMSS conference. Viewed as the pinnacle for new product launches in digital health, the exhibition floor at HIMSS also offers a glimpse of the future and a reflection of the state of healthcare IT today.As the HIMSS organizers galvanize attendees with their call “champions of health unite”,
Read More
Caradigm Sale – The Final Step in GE’s Exit From PHM/Value-based Care?
- On 13th June 2018, cancer informatics and digital pathology workflow vendor, Inspirata, announced that it was purchasing GE Healthcare’s remaining population health management (PHM) interest, Caradigm- This follows the announcement in April 2018 that GE Healthcare was selling its ambulatory value-based care business to Veritas Capital- This latest announcement now means that GE Healthcare has exited the population health management market from both an enterprise and ambulatory perspective- It
Read More
